We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Caspase-1 genetic variation is not associated with Alzheimer's disease risk.
- Authors
Vázquez-Higuera, José Luis; Rodríguez-Rodríguez, Eloy; Sánchez-Juan, Pascual; Mateo, Ignacio; Pozueta, Ana; Martínez-García, Ana; Frank, Ana; Valdivieso, Fernando; Berciano, José; Bullido, María J.; Combarros, Onofre
- Abstract
Background: Interleukin (IL)-1β is a potent proinflammatory cytokine markedly overexpressed in the brains of patients with Alzheimer's disease (AD), and also involved in development of atherosclerosis and coronary artery disease. Caspase-1 (CASP1), formerly called IL-1β converting enzyme (ICE), mediates the cleavage of the inactive precursor of IL-1β into the biologically active form. CASP1 genetic variation (G+7/in6A, rs501192) has been associated with susceptibility to myocardial infarction and cardiovascular death risk. We examined the contribution of this gene to the susceptibility for AD. Methods: We examined genetic variations of CASP1 by genotyping haplotype tagging SNPs (htSNPs) (rs501192, rs556205 and rs530537) in a group of 628 Spanish AD cases and 722 controls. Results: There were no differences in the genotypic, allelic or haplotypic distributions between cases and controls in the overall analysis or after stratification by age, gender or APOE ϵ4 allele. Conclusion: Our negative findings in the Spanish population argue against the hypothesis that CASP1 genetic variations are causally related to AD risk.
- Subjects
ALZHEIMER'S disease; HUMAN genetic variation; ATHEROSCLEROSIS; ANGIOTENSIN converting enzyme; MYOCARDIAL infarction
- Publication
BMC Medical Genetics, 2010, Vol 11, p32
- ISSN
1471-2350
- Publication type
Article
- DOI
10.1186/1471-2350-11-32